CD4 counts as surrogate markers for progression to AIDS.
作者信息
Phillips A N, Sabin C A
出版信息
Ann Intern Med. 1994 Jan 1;120(1):87-8. doi: 10.7326/0003-4819-120-1-199401010-00018.
Abstract
摘要
相似文献
1
CD4 counts as surrogate markers for progression to AIDS.
Ann Intern Med. 1994 Jan 1;120(1):87-8. doi: 10.7326/0003-4819-120-1-199401010-00018.
2
CD4 counts as surrogate markers for progression to AIDS.
Ann Intern Med. 1994 Jan 1;120(1):88. doi: 10.7326/0003-4819-120-1-199401010-00019.
3
CD4 counts as surrogate markers for progression to AIDS.CD4计数作为进展为艾滋病的替代标志物。
Ann Intern Med. 1994 Jan 1;120(1):87; author reply 88. doi: 10.7326/0003-4819-120-1-199401010-00017.
4
Lymphocytes' intrinsic lymphoproliferative capacity in patients with AIDS treated with zidovudine.接受齐多夫定治疗的艾滋病患者淋巴细胞的内在淋巴细胞增殖能力。
AIDS. 1989 Oct;3(10):671-3. doi: 10.1097/00002030-198910000-00013.
5
CD4+ lymphocytes are an incomplete surrogate marker for clinical progression in persons with asymptomatic HIV infection taking zidovudine.对于正在服用齐多夫定的无症状HIV感染者，CD4 + 淋巴细胞是临床进展的不完整替代标志物。
Ann Intern Med. 1993 May 1;118(9):674-80. doi: 10.7326/0003-4819-118-9-199305010-00003.
6
Evaluating the role of CD4-lymphocyte counts as surrogate endpoints in human immunodeficiency virus clinical trials.评估CD4淋巴细胞计数作为人类免疫缺陷病毒临床试验替代终点的作用。
Stat Med. 1993 May 15;12(9):835-42. doi: 10.1002/sim.4780120904.
7
Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS).
Ann Intern Med. 1990 Jun 1;112(11):812-21. doi: 10.7326/0003-4819-112-11-812.
8
[Another AIDS drug. Azidothymidine--dideoxycytidine].[另一种艾滋病药物。叠氮胸苷——双脱氧胞苷]
Fortschr Med. 1992 Jun 30;110(18):28-30.
9
The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.齐多夫定（AZT）治疗轻度症状的1型人类免疫缺陷病毒（HIV）感染患者的安全性和有效性。一项双盲、安慰剂对照试验。艾滋病临床试验组。
Ann Intern Med. 1990 May 15;112(10):727-37. doi: 10.7326/0003-4819-112-10-727.
10
Evolution of zidovudine dosing.齐多夫定剂量的演变
Ann Pharmacother. 1992 Jun;26(6):784-5.
Zotero 插件